What We Do
Commitment to Innovation
Our venture is developing a therapeutic targeting elevated endothelin-1 levels that may be used in diabetes, cardiovascular and neurodegenerative diseases, different cancers as also pregnancy disorders.
Drug Development
We believe we have discovered a potent therapy for diabetes, both type 1 and type 2, as well as a potential treatment for cardiovascular and other disorders.